SCHEMBL6233129

SCHEMBL6233129

c1ccc2nc(C3CNCCN3)cnc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
KDM4E B2RXH2 3/20 0.37
GAA P10253 2/20 0.37
ALOX15 P16050 2/20 0.37
MAPT P10636 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
ADORA3 P0DMS8 2/20 0.36
BMPR1B O00238 1/20 0.36
PDGFRB P09619 1/20 0.36
KDR P35968 1/20 0.36
ACVR1B P36896 1/20 0.36
TGFBR1 P36897 1/20 0.36
TGFBR2 P37173 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9733257 0.79 CYP3A4 (0.41) CYP1A2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL19668632 0.79 TAAR1 (0.48) CYP1A2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL28800404 0.77 KDM4E (0.39) CYP1A2KDM4EMAPTBMPR1BPDGFRB
SCHEMBL6233506 0.74 BMPR1B (0.36) CYP1A2KDM4EBMPR1BPDGFRBKDR
SCHEMBL987383 0.73 DDB1 (0.37) CYP1A2NPC1RAB9AKDM4EMAPT
SCHEMBL20993216 0.73 DDB1 (0.37) CYP1A2NPC1RAB9AKDM4EMAPT
SCHEMBL20993362 0.73 DDB1 (0.37) CYP1A2NPC1RAB9AKDM4EMAPT
SCHEMBL28156000 0.73 HRH1 (0.44)
SCHEMBL3703819 0.72 MEN1 (0.55) CYP1A2NPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL6965524 0.72 DDB1 (0.36) CYP1A2NPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025097-B1 1-(2-NAPHTHYL) AND 1-(2-AZANAPHTHYL)-4-(1-PHENYLMETHYL)PIPERAZINES BEING DOPAMINE D 4? RECEPTOR SUBTYPE LIGANDS NEUROGEN CORP (US) 2005-04-27 EP disclosed
CN-1191248-C 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype ligands NEUROGEN CORP (US) 2005-03-02 CN disclosed
US-6384224-B2 FOR THERAPY AND PROPHYLAXIS OF PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA AND OTHER CENTRAL NERVOUS SYSTEM DISEASE NEUROGEN CORPORATION 2002-05-07 US disclosed
US-6331629-B1 TREATMENT OF NEURO-PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2001-12-18 US disclosed
US-6040448-A USEFUL FOR TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA AND OTHER CENTRAL NERVOUS SYSTEM DISEASES. NEUROGEN CORPORATION (US) 2000-03-21 US disclosed